| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |